Press Releases
Biogen and Eisai Expand Existing Collaboration Agreement to Develop...
Eisai Co., Ltd. and Biogen Inc. announced today that the companies have expanded their existing agreement to jointly develop and commercialize investigational Alzheimer's disease treatments....
Press Releases
Nanobiotix Completes Patient Inclusion for Phase II/III Trial of...
NANOBIOTIX , a late clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, announced that it has completed patient inclusion for the Phase...
Press Releases
KalVista Pharmaceuticals Announces Collaboration with Merck
KalVista Pharmaceuticals, Inc , a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors announced that it has...
Press Releases
EAHP Congress – register as a participant and submit...
Gothenburg in Sweden, a beautiful city with an exciting cultural life will be the destination of the 23rd Congress of the European Association of Hospital...
Press Releases
Sangamo And Bioverativ Announce FDA Acceptance Of IND Application...
Sangamo Therapeutics, Inc. the leader in therapeutic genome editing, and Bioverativ Inc. (NASDAQ: BIVV), a global biopharmaceutical company focused on the discovery, development, and commercialization...
Press Releases
TrialScope Tackles Issue of “Sharing Clinical Trial Results with...
TrialScope, the global leader in clinical trial transparency and compliance solutions, announced new findings from its sponsor survey on clinical trial results sharing practices, at...
Press Releases
GSK receives approval for Benlysta in Japan for the...
GSK announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Benlysta (belimumab) for the treatment of adult patients with systemic...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.